By MIKE MAGEE What are the chances that citizens of New York, the largest city in the nation, would vote in a majority to oppose a formerly corrupt politician with a party machine behind him, and instead favor a little known candidate – the son of immigrant parents with “swarthy skin and belligerent independence,” from…
In 40 percent of attacks, threat actors threatened to physically harm executives at organizations that declined to pay a ransom demand, study states
A judge recently blocked an Arkansas law that would have banned PBMs from owning and operating pharmacies in the state. Although the state plans to appeal, one expert says the law likely has no future. The post Will the Arkansas PBM Law Survive A Judge’s Rejection? appeared first on MedCity News.
NIH documents viewed by KFF Health News show a pronounced decline in patients at the 200-bed NIH hospital from February through April
Jazz Pharmaceuticals’ dordaviprone, brand name Modeyso, is now the first FDA-approved therapy for recurrent H3 K27M-mutant diffuse midline glioma. The drug came from Jazz’s $935 million acquisition of Chimerix earlier this year. The post Rare and Aggressive Brain Cancer Affecting Children Gets Its First FDA-Approved Drug appeared first on MedCity News.
This brief examines state consent requirements for minors accessing contraceptive and abortion care, processes for minors to attempt to obtain abortion without parental involvement, and trends in state policy increasing requirements for parental involvement in minors’ health care decisions.
The move will save the behavioral healthcare company about $100 million over the next few years.
Q&A with Alan Weiss, M.D., M.B.A., Banner Health’s senior vice president of clinical advancement
The Host Emmarie Huetteman KFF Health News Emmarie Huetteman, senior editor, oversees a team of Washington reporters, as well as “Bill of the Month” and KFF Health News’ “What the Health?” She previously spent more than a decade reporting on the federal government, most recently covering surprise medical bills, drug pricing reform, and other health policy debates…
The Trump administration’s Make America Healthy Again nutrition policies and Medicare Advantage plan ethics were prominent themes on the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and guest co-host Paul Markovich, CEO of Blue Shield of California parent company Ascendiun. The post Debunked Episode 18: Unpacking MAHA, Nutrition on a…